Find a metastatic breast cancer trial that's right for you.

Play Video

How does Metastatic Trial Search work?

Answer questions about your diagnosis
View matched trials in patient-friendly language
Login/Register at any time and save your profile to receive Trial Alerts

Find a metastatic breast cancer trial that's right for you.

GET STARTED HERE

New to Clinical Trials?

New to Clinical Trials?

The idea of finding and entering a clinical trial can seem daunting. Use the following links to get started on the path to finding a trial that might be right for you.

NEWS & PUBLICATIONS

Metastatic Breast Cancer Research and Clinical Trials.

The latest clinical trials, research, and treatment options for you to share and discuss with your doctor.

SPECIAL TOPICS

Trial Alerts: Now Available on Metastatic Trial Search!

Read about our new feature, Trial Alerts, which are emails sent once a week when new trials posted on Metastatic Trial Search match your…
RESEARCH NEWS

Dato-DXd Antibody-Drug Conjugate for Triple-Negative and Hormone Receptor-Positive MBC

Learn about how ADCs work and for research news about…
NEW TRIALS

New Clinical Trials For Stage IV Breast Cancer

Cancer can bring a lot of questions, but our helpful resources can bring you clarity and peace of mind. Find the answers you want quickly on a range of topics. In language written by actual humans!
FROM THE EXPERTS

Managing Side Effects of ADCs

Hear from experts about strategies to help prevent or reduce side effects to increase the ability to stay on treatment and improve quality of life…

Additional Links and Resources

The latest clinical trials, research, and treatment options for you to share and discuss with your doctor.

40-site U.S. trial enrolling more than 300 patients could significantly change the way DCIS is treated and reduce possibly unnecessary surgery
After years of watching women diagnosed with the disease get the same, drastic treatment of disfiguring surgery or brutal chemotherapy and radiation, Esserman believed doctors not only could but should be able to do better.
Quantum Leap Healthcare Collaborative™ today announced that Arvinas’ vepdegestrant (ARV-471), a novel PROTAC® estrogen receptor (ER) protein degrader being co-developed with Pfizer Inc. will be evaluated in the ongoing I-SPY TRIAL endocrine program sponsored by Quantum Leap.
Quantum Leap Healthcare Collaborative (QLHC) announces the mobile responsive launch of its metastatic breast cancer clinical trial matching service, Metastatic Trial Search (MTS). This launch expands MTS's reach to a broader range of breast cancer patient groups with a goal of reaching a more diverse population including those under-represented in clinical trials.

A leap in research happens with world-class partners.

We are grateful to our Platinum, Gold, Silver, and Bronze sponsors for their unrestricted and generous support.

Contact Us
Investigators Portal
QLHC in the News
Working at QL
Contact Us